Alcon (ALC)
(Delayed Data from NYSE)
$94.47 USD
-1.23 (-1.29%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $94.42 -0.05 (-0.05%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth C Momentum D VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Net Sales: Total Surgical: Implantables
- 1,703.00
- 1,725.00
- 1,522.00
- 1,126.00
- 1,210.00
- Revenue - Line of Business (LOBR)
- Net Sales: Total Surgical: Consumables
- 2,719.00
- 2,499.00
- 2,388.00
- 1,952.00
- 2,304.00
- Revenue - Line of Business (LOBR)
- Net Sales: Total Surgical: Equipment/other
- 892.00
- 821.00
- 793.00
- 632.00
- 660.00
- Revenue - Line of Business (LOBR)
- Net Sales: Total Vision Care: Contact lenses
- 2,400.00
- 2,192.00
- 2,139.00
- 1,838.00
- 1,969.00
- Revenue - Line of Business (LOBR)
- Net Sales: Total Vision Care: Ocular health
- 1,656.00
- 1,417.00
- 1,380.00
- 1,215.00
- 1,219.00
- Revenue - Line of Business (LOBR)
- Net Sales: Total Surgical
- 5,314.00
- 5,045.00
- 4,703.00
- 3,710.00
- 4,174.00
- Revenue - Line of Business (LOBR)
- Net Sales: Total Vision care
- 4,056.00
- 3,609.00
- 3,519.00
- 3,053.00
- 3,188.00
- Revenue - Line of Business (LOBR)
- Revenues: Other revenues
- 85.00
- 63.00
- 69.00
- 70.00
- 146.00
- Revenue - Geographic (GEOR)
- Net sales by region: International
- 5,058.00
- 4,757.00
- 4,571.00
- 3,788.00
- --
- Income - Line of Business (LOBI)
- Operating Income: Surgical
- 1,454.00
- 1,336.00
- 1,184.00
- 672.00
- --
- Income - Line of Business (LOBI)
- Operating Income: Vision Care
- 777.00
- 600.00
- 604.00
- 419.00
- --
- Income - Line of Business (LOBI)
- Operating Income: Not allocated to segments
- -1,192.00
- -1,264.00
- -1,208.00
- --
- --
- Income - Line of Business (LOBI)
- Operating Income: Core adjustments
- 810.00
- 899.00
- 863.00
- --
- --